Purchase this article with an account.
Adrian Au, Vishal Parikh, Yasha Modi, Justis P Ehlers, Andrew Schachat, Rishi P Singh; Pilot Study Determining Impact of Best Practices Alerts on Hydroxychloroquine Screening Practice Patterns. Invest. Ophthalmol. Vis. Sci. 2016;57(12):301.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
The purpose of this study was to determine the initial impact of the best practice alert (BPA) on hydroxychloroquine (HCQ) retinopathy screening practice patterns at one multispecialty ophthalmic practice.
This was an observational, retrospective study and approval from the institutional review board was obtained. Responses and screening tests for all patients were analyzed after the implementation of a BPA in the electronic medical record (August 2015 to December 2015). Screenings were classified as: “appropriate” when an objective (SD-OCT, mfERG, FAF) and a subjective test (HVF) were performed; “under-testing” when either a 10-2 HVF or objective testing was performed; “inappropriate” if neither 10-2 HVF or objective testing was performed.
Out of the 84 HCQ screening encounters that occurred after the implementation of the BPA, 57 (67.9%) were appropriately screened, 17 (20.2%) were under-screened, and 2 (2.4%) were inappropriately screened. This is in contrast to the previously described screening adherence at the same multispecialty ophthalmic practice where 54.8% were appropriately screened, 25.7% were under-screened, and 19.5% were inappropriately screened (Au et al. 2015). 10-2 HVF and SD-OCT were the preferred testing modalities at 77.6% and 93.4%, respectively.
Screening for HCQ retinopathy improved with the implementation of a best practice alert as appropriate screening improved from 55% to 67.9% while those inappropriately screened decreased from 19.5% to 2%.
This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.
This PDF is available to Subscribers Only